Hereditary Central Nervous System Demyelinating Diseases

These are inherited conditions where the protective covering around nerve cells in the brain and spinal cord gets damaged or lost. This damage makes the nerves less able to send signals properly. It's a genetic condition affecting the central nervous system.

Condition

What people with Hereditary Central Nervous System Demyelinating Diseases report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Hereditary Central Nervous System Demyelinating Diseases?

NameHow it went

About Hereditary Central Nervous System Demyelinating Diseases

What It Is

Hereditary central nervous system demyelinating diseases are inherited conditions that damage myelin, the fatty insulating layer around nerve fibers in the brain and spinal cord. Myelin lets nerve signals travel quickly. When it fails to form properly or breaks down, messages between nerve cells slow or stop, and people gradually lose abilities such as walking, balance, speech, swallowing, vision, hearing or clear thinking. Seizures, stiff muscles and changes in behavior or learning are also common. Most of these conditions are better known as leukodystrophies, a family of more than 50 rare genetic diseases. Well-known examples include X-linked adrenoleukodystrophy (ALD), metachromatic leukodystrophy (MLD), Krabbe disease, Alexander disease, Canavan disease and Pelizaeus-Merzbacher disease. Some begin in infancy, others in childhood, and a few mainly in adulthood. Most get worse over time, but the specific type largely determines the age symptoms start, how fast they progress and whether an effective treatment exists. They are different from multiple sclerosis, in which the immune system attacks myelin.

Causes & Risk Factors

Each of these diseases is caused by a change in a single gene that the body needs to build, maintain or recycle myelin or the cells that support it. In some types, a missing enzyme lets a fatty substance build up to toxic levels; in others, a structural myelin protein or a supporting brain cell does not work properly. Nothing a person or parent did causes the disease, and there are no lifestyle triggers. How the gene change is passed on depends on the type. Krabbe disease, MLD and Canavan disease are autosomal recessive: a child is affected only after inheriting a changed copy of the gene from each parent, and the parents, who each carry one copy, usually have no symptoms. ALD and Pelizaeus-Merzbacher disease are X-linked: the gene sits on the X chromosome, of which males have one copy and females two, so boys and men are usually affected more severely, while women who carry the gene may have milder symptoms, often later in life. Alexander disease usually comes from a new gene change in a child with no family history. Because the pattern differs, a confirmed diagnosis matters for brothers, sisters and other relatives as well as for the person affected.

How It's Diagnosed

Diagnosis starts with a careful history, including whether a child has lost skills they once had, and a physical and neurological exam. Magnetic resonance imaging (MRI) of the brain is central. It shows the white matter, the myelin-rich parts of the brain, and the pattern of damage often points toward particular types. Genetic testing then confirms the specific disease. When a single-gene test does not settle the question, exome or genome sequencing, which reads most or all of a person's genes at once, can identify the cause. For some types, blood tests add useful evidence, such as measuring very long chain fatty acids (fats that build up in the blood because the body cannot break them down) in ALD or the activity of a missing enzyme in Krabbe disease and MLD. Some cases are now found before symptoms appear. ALD and the infantile form of Krabbe disease are on the recommended newborn screening panel in the United States, although not every state screens for every condition. In adults, these diseases can produce MRI changes and symptoms that look like multiple sclerosis (MS). Getting the correct diagnosis matters, because MS medicines that calm the immune system do not treat a genetic myelin disease, and a confirmed diagnosis opens the door to genetic counseling and any treatment specific to that type.

Treatment Options

For most types there is no cure, and care focuses on preserving function and comfort. Medicines can ease muscle stiffness (spasticity) and control seizures. Physical, occupational and speech therapy help with movement, daily tasks and communication. Nutrition support helps when eating and swallowing become difficult, and educational and recreational programs help children and adults stay engaged in daily life. A few types have treatments that can change the course of the disease, but mainly when given before symptoms start or very early. A stem cell transplant from a matched donor has been shown to help in early cerebral ALD (the form that affects the brain, mostly in boys) and in later-onset MLD caught before or just as symptoms start, by supplying cells that can make what the body lacks. For infantile Krabbe disease, a transplant is ideally done within the first month of life. Two one-time gene therapies use a person's own blood-forming stem cells, corrected in a laboratory and returned by infusion. Atidarsagene autotemcel (Lenmeldy) is approved for children with the late infantile or early juvenile forms of MLD who have no symptoms yet, and for children with the early juvenile form whose symptoms have only just begun. Elivaldogene autotemcel (Skysona) is approved for some boys with early, active cerebral ALD who do not have a matched donor, and it carries an increased risk of blood cancer that requires long-term monitoring. Both transplant and gene therapy require high-dose chemotherapy first, are offered at specialized centers, and do not restore abilities already lost. People with ALD also need regular checks of adrenal gland function, because the disease often damages the adrenal glands and the resulting hormone shortage is treatable. Clinical trials are testing new approaches for several other leukodystrophies.

What to Expect

The course depends heavily on the specific disease and when it begins. Infant-onset forms such as infantile Krabbe disease or Canavan disease usually progress quickly, with serious disability in early childhood and, for many children, a shortened life. Later-onset forms tend to move more slowly; an adult with a leukodystrophy may live for many years with gradually increasing stiffness, walking difficulty, bladder problems or changes in thinking. Even within one disease, such as ALD, one family member may develop rapid brain involvement while another has mild symptoms in adulthood. Living with a leukodystrophy usually means care from a team that may include a neurologist, geneticist, rehabilitation therapists, a dietitian and, for ALD, an endocrinologist. Children found through newborn screening or family testing often have regular MRI scans and blood tests so treatment can start at the first sign of brain involvement. As needs change, families often plan for mobility aids, school support and help at home. The caregiving load can be heavy, and support groups for specific leukodystrophies connect families with others who understand the condition.

When to Seek Help

Arrange an evaluation if an infant or child loses skills they previously had, such as walking, talking or feeding, or if an adult develops slowly worsening stiffness, unsteadiness or thinking problems without a clear cause. Ask about genetic testing if a relative has been diagnosed with one of these diseases, especially before or soon after the birth of a new baby. Contact the care team promptly if a boy known to have ALD shows new trouble at school, a change in behavior, vision problems or clumsiness, since these can be the first signs of brain involvement while treatment can still help. Also call promptly if someone with ALD develops vomiting, unusual weakness or tiredness, weight loss or darkening of the skin, which can mean the adrenal glands are failing. Vomiting that will not stop, severe weakness, confusion, extreme drowsiness or fainting can be an adrenal crisis: if the person has a prescribed emergency hydrocortisone injection, give it, and call 911 or go to the emergency room right away.

Questions to Ask Your Doctor

  1. 1.Which specific disease is this, and what does that type usually mean for the coming years?
  2. 2.Is a stem cell transplant, gene therapy or clinical trial an option at this stage, and what are the trade-offs?
  3. 3.Which relatives should be offered genetic testing or counseling, and what would a positive result mean for them?
  4. 4.What symptoms should prompt an earlier call or scan between scheduled visits?
  5. 5.Which therapies, equipment and support services would help most with daily life right now?

Last reviewed • Oct 2026

Educational content, not medical advice.